Anna H Yeung1, Meredith Temple-Smith2, Christopher K Fairley3, Alaina M Vaisey3, Rebecca Guy4, Matthew G Law4, Nicola Low5, Amie L Bingham3, Jane Gunn2, John Kaldor4, Basil Donovan4, Jane S Hocking3. 1. Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. ayeung@unimelb.edu.au. 2. General Practice and Primary Health Care Academic Centre, University of Melbourne, Melbourne, VIC, Australia. 3. Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. 4. Kirby Institute, University of New South Wales, Sydney, NSW, Australia. 5. Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Abstract
OBJECTIVE: To estimate chlamydia prevalence among 16-29-year-olds attending general practice clinics in Australia. DESIGN, PARTICIPANTS AND SETTING: A cross-sectional survey was conducted from May 2010 to December 2012. Sexually experienced 16-29-year-olds were recruited from 134 general practice clinics in 54 rural and regional towns in four states and in nine metropolitan clinics (consecutive patients were invited to participate). Participants completed a questionnaire and were tested for chlamydia. MAIN OUTCOME MEASURE: Chlamydia prevalence. RESULTS: Of 4284 participants, 197 tested positive for chlamydia (4.6%; 95% CI, 3.9%-5.3%). Prevalence was similar in men (5.2% [65/1257]; 95% CI, 3.9%-6.4%) and women (4.4% [132/3027]; 95% CI, 3.5%-5.2%) (P = 0.25) and high in those reporting genital symptoms or a partner with a sexually transmissible infection (STI) - 17.0% in men (8/47; 95% CI, 2.8%-31.2%); 9.5% in women (16/169; 95% CI, 5.1%-13.8%). Nearly three-quarters of cases (73.4% [130/177]) were diagnosed in asymptomatic patients attending for non-sexual health reasons, and 83.8% of all participants (3258/3890) had attended for non-sexual health reasons. Prevalence was slightly higher in participants from rural and regional areas (4.8% [179/3724]; 95% CI, 4.0%-5.6%) than those from metropolitan areas (3.1% [17/548]; 95% CI, 1.5%-4.7%) (P = 0.08). In multivariable analysis, increasing partner numbers in previous 12 months (adjusted odds ratio [AOR] for three or more partners, 5.11 [95% CI, 2.35-11.08]), chlamydia diagnosis in previous 12 months (AOR, 4.35 [95% CI, 1.52-12.41]) and inconsistent condom use with most recent partner (AOR, 2.90 [95% CI, 1.31-6.40]) were significantly associated with chlamydia in men. In women, increasing partner numbers in previous 12 months (AOR for two partners, 2.59 [95% CI, 1.59-4.23]; AOR for three or more partners, 3.58 [95% CI, 2.26-5.68]), chlamydia diagnosis in previous 12 months (AOR, 3.13 [95% CI, 1.62-6.06]) and age (AOR for 25-29-year-olds, 0.23 [95% CI, 0.12-0.44]) were associated with chlamydia. CONCLUSIONS: Chlamydia prevalence is similar in young men and women attending general practice. Testing only those with genital symptoms or a partner with an STI would have missed three-quarters of cases. Most men and women are amenable to being tested in general practice, even in rural and regional areas.
OBJECTIVE: To estimate chlamydia prevalence among 16-29-year-olds attending general practice clinics in Australia. DESIGN, PARTICIPANTS AND SETTING: A cross-sectional survey was conducted from May 2010 to December 2012. Sexually experienced 16-29-year-olds were recruited from 134 general practice clinics in 54 rural and regional towns in four states and in nine metropolitan clinics (consecutive patients were invited to participate). Participants completed a questionnaire and were tested for chlamydia. MAIN OUTCOME MEASURE: Chlamydia prevalence. RESULTS: Of 4284 participants, 197 tested positive for chlamydia (4.6%; 95% CI, 3.9%-5.3%). Prevalence was similar in men (5.2% [65/1257]; 95% CI, 3.9%-6.4%) and women (4.4% [132/3027]; 95% CI, 3.5%-5.2%) (P = 0.25) and high in those reporting genital symptoms or a partner with a sexually transmissible infection (STI) - 17.0% in men (8/47; 95% CI, 2.8%-31.2%); 9.5% in women (16/169; 95% CI, 5.1%-13.8%). Nearly three-quarters of cases (73.4% [130/177]) were diagnosed in asymptomatic patients attending for non-sexual health reasons, and 83.8% of all participants (3258/3890) had attended for non-sexual health reasons. Prevalence was slightly higher in participants from rural and regional areas (4.8% [179/3724]; 95% CI, 4.0%-5.6%) than those from metropolitan areas (3.1% [17/548]; 95% CI, 1.5%-4.7%) (P = 0.08). In multivariable analysis, increasing partner numbers in previous 12 months (adjusted odds ratio [AOR] for three or more partners, 5.11 [95% CI, 2.35-11.08]), chlamydia diagnosis in previous 12 months (AOR, 4.35 [95% CI, 1.52-12.41]) and inconsistent condom use with most recent partner (AOR, 2.90 [95% CI, 1.31-6.40]) were significantly associated with chlamydia in men. In women, increasing partner numbers in previous 12 months (AOR for two partners, 2.59 [95% CI, 1.59-4.23]; AOR for three or more partners, 3.58 [95% CI, 2.26-5.68]), chlamydia diagnosis in previous 12 months (AOR, 3.13 [95% CI, 1.62-6.06]) and age (AOR for 25-29-year-olds, 0.23 [95% CI, 0.12-0.44]) were associated with chlamydia. CONCLUSIONS: Chlamydia prevalence is similar in young men and women attending general practice. Testing only those with genital symptoms or a partner with an STI would have missed three-quarters of cases. Most men and women are amenable to being tested in general practice, even in rural and regional areas.
Authors: Anna Yeung; Meredith Temple-Smith; Simone Spark; Rebecca Guy; Christopher K Fairley; Matthew Law; Anna Wood; Kirsty Smith; Basil Donovan; John Kaldor; Jane Gunn; Marie Pirotta; Rob Carter; Jane Hocking Journal: BMC Infect Dis Date: 2014-11-07 Impact factor: 3.090
Authors: Eric P F Chow; Rebecca Wigan; Anna McNulty; Charlotte Bell; Mandy Johnson; Lewis Marshall; David G Regan; Louise Owen; Julia M L Brotherton; Catriona S Bradshaw; Christopher K Fairley; Darren Russell; Marcus Y Chen Journal: BMJ Open Date: 2017-10-15 Impact factor: 2.692
Authors: Belinda K Ford; Marlene Kong; James S Ward; Jane S Hocking; Christopher K Fairley; Basil Donovan; Rebecca Lorch; Simone Spark; Matthew Law; John Kaldor; Rebecca Guy Journal: BMC Health Serv Res Date: 2019-08-14 Impact factor: 2.655
Authors: Rebecca J Guy; Joanne M Micallef; Julie Mooney-Somers; Muhammad S Jamil; Caroline Harvey; Deborah Bateson; Caroline van Gemert; Handan Wand; John Kaldor Journal: J Med Internet Res Date: 2016-06-24 Impact factor: 5.428